← Product Code [BZD](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/BZD) · K061099 # BREATHX NASAL PILLOW AND MASK SYSTEM, MODEL 011-0003 (K061099) _Hoffman Laboratories, LLC · BZD · Aug 11, 2006 · Anesthesiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/BZD/K061099 ## Device Facts - **Applicant:** Hoffman Laboratories, LLC - **Product Code:** [BZD](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/BZD.md) - **Decision Date:** Aug 11, 2006 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 868.5905 - **Device Class:** Class 2 - **Review Panel:** Anesthesiology - **Attributes:** Therapeutic ## Indications for Use The BreatheX Nasal Interface System is an accessory intended for use with devices that deliver Continuous Positive Airway Pressure (CPAP) and bi-level positive airway pressure in treating adult patients. Caution: Federal law restricts this device to sale by or on the order of a physician. ## Device Story BreatheX Nasal Interface System is a CPAP accessory; consists of plastic manifold, nasal mask cushion, nasal pillows, adjustable headgear, and 22mm interface tube. Device connects to CPAP/bi-level machines to deliver pressurized air to adult patients. Manifold features integral exhaust port to vent expired gases and minimize rebreathing. Used in home or sleep clinic settings; operated by patient. Lightweight design intended for comfort; allows interchangeability between nasal pillows and mask cushion. Single-patient use device. ## Clinical Evidence No clinical data. Bench testing only. Performance verified via environmental, shock, vibration, and moisture ingress testing. Static and dynamic performance (dead space, pressure-flow, sound output) compared to predicates; results met specifications. Biocompatibility and risk/hazard analyses performed. ## Technological Characteristics Rigid plastic manifold; soft silicone rubber seal; adjustable flexible headgear straps. 22mm interface tube fitting. Integral exhaust port for gas venting. Single-patient use. No electronic components or software. ## Regulatory Identification A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing. ## Predicate Devices - Lyra Nasal Interface ([K031883](/device/K031883.md)) - Ultra Mirage II Mask ([K050359](/device/K050359.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K061099 AUG 1 1 2006 ## Summary of Safety and Effectiveness in accordance with 21 CFR 807.92 Company Name: Hoffman Laboratories, LLC 9305 Eton Ave Chatsworth CA 91311 Contact: Keith Bosecker, President Phone: 818-341 4131 Fax: 818-341 4135 Email: keith_bosecker@hoffmanlaboratories.com Summary Date: April 14, 2006 Trade Name: Hoffman Laboratories BreatheX™ Nasal Interface System Common Name: CPAP Device Accessory Common Classification/Name: Ventilator, non-continuous, non-life supporting Product Code(s): 21 CFR 868.5905 BZD Class: Class II Predicate Devices: - 510K Number: K031883 ● - Manufacturer: SensorMedics Corporation (VIASYS) . - Lyra Nasal Interface . Trade Name: - 510K Number: K050359 . - Manufacturer: ResMed Limited . - Ultra Mirage II Mask Trade Name: ● Reason for Submission: New Device {1}------------------------------------------------ ## Description of Device The BreatheX Nasal Interface System has been designed for use as an accessory with commonly marketed CPAP units. The device consists of a plastic manifold with integral exhaust port, nasal mask cushion, a set of nasal pillows, adjustable headgear straps, and an interface tube with a 22mm fitting. The Nasal Interface System allows a patient to use either the nasal pillows or nasal mask cushion interchangeably. The lightweight construction of the device is designed to maximize patient comfort. The device is labeled for single patient use. #### Intended Use The BreatheX Nasal Interface System is intended for use as accessory device to CPAP machines in the treatment of obstructive sleep apnea (OSA). The BreatheX Nasal Interface System is for use on adult spontaneously breathing (non-ventilator dependant) patients at home or in the sleep clinic. ## Indications for Use The BreatheX Nasal Interface System is an accessory intended for use with devices that deliver Continuous Positive Airway Pressure (CPAP) and bi-level positive airway pressure in treating adult patients. Caution: Federal law restricts this device to sale by or on the order of a physician. ## Technology The BreatheX Nasal Interface device utilizes similar technological characteristics as the predicate devices. All devices utilize a rigid plastic manifold with a soft silicone rubber seal to the area around the nose or the nasal passages. All devices are attached to the patient's head using flexible adjustable straps. Like the predicate devices, the manifold of the BreatheX Nasal Interface System has an integral exhaust port which continuously vents a portion of the CPAP treatment air in order to minimize the rebreathing of expired gases. {2}------------------------------------------------ ## Non-Clinical Tests Submitted: The device was tested in accordance with applicable standards for medical device environmental temperature and humidity, shock and vibration, and moisture ingress. The BreatheX Nasal Interface System passed all of the tests. Static and dynamic performance testing was conducted in comparison with the predicate devices for dead space, pressure-flow characteristics and sound output level. The device met specified requirements and was comparable to the applicable specifications of the predicate devices. The materials utilized in the device comply with biocompatibility requirements appropriate for the intended use. Risk and Hazard analyses were performed, and the results of the analyses demonstrated that the residual risks were acceptable for the intended use. ## Clinical Tests Submitted: None ## Conclusions The function of the BreatheX Nasal Interface System is substantially equivalent to the predicate devices. Laboratory and standards compliance tests are provided to support the safety and performance of the device. As described above, all of the testing demonstrates that the Hoffman Laboratories BreatheX Nasal Interface System is as safe and effective and performs in a manner equivalent to the predicate nasal interface devices. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, with three intertwined lines representing the branches of government. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" is arranged in a circular pattern around the caduceus. The seal is black and white. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## AUG 1 1 2006 Mr. Keith Bosecker President Hoffman Laboratories, LLC 9305 Eton Avenue Chatsworth, California 91311 Re: K061099 Trade/Device Name: Hoffman Laboratories BreatheXTM Nasal Interface System Regulation Number: 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: August 3, 2006 Received: August 7, 2006 Dear Mr. Bosecker: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the federal Register. {4}------------------------------------------------ #### Page 2 - Mr. Bosecker Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrlv/industry/support/index.html. Sincerely yours, Smitte Y. Michie Davis Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Indications for Use 510(k) Number (if known): Hoffman Laboratories BreatheX™ Nasal Interface System Device Name: Indications for use: The BreatheX Nasal Interface System is an accessory intended for use with devices that deliver Continuous Positive Airway Pressure (CPAP) and bi-level positive airway pressure in treating adult patients. Caution: Federal law restricts this device to sale by or on the order of a physician. Prescription Use __ × (Part 21 CFR 801 Subpart D) AND / OR Over-The-Counter Use _ (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Sua Rump ion of Anestheaningy General Hospital, Control, Dental Devices ) Number. K061099 Page 1 of _1 _ --- **Source:** [https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/BZD/K061099](https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/BZD/K061099) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com